Editorial
(1125) Total Article Views
Authors: Shiekh FA
Published Date January 2013 Volume 2013:8 Pages 201 - 202
DOI: http://dx.doi.org/10.2147/IJN.S41525
Farooq A Shiekh
Avalon University School of Medicine, Willemstad, Curacao
Cancer as a grave disease is becoming a larger health problem,1 and the medicines used as treatments have clear limitations.2?4 Chemotherapy, radiation, and surgery, all of which are drastic treatments, wreak havoc on healthy cells and tissues as well as cancerous ones.5?7 Pathophysiologically, there are more than 200 types of cancers,8,9 each with many variants.10 Some are aggressive, some are not; some are easily treated, and others are always fatal.11
Unlike previous "revolutions" in the "war" on cancer that raised hope, nanomedicine is not just one more tool, it is an entire field, and the science in this area is burgeoning, and benefiting from use of modern cutting edge molecular tools.12?14 These breakthrough advancements have radically changed the perception of future medicine. Importantly, they are enabling landmark research to combine all advances, creating nanosized particles that contain drugs targeting cell surface receptors and other potent molecules designed to kill cancerous cells.15?19 If there is a case to be made for personalized medicine, cancer is it. For example, the current literature reveals the need for a great scientific effort to be made in this field.20?22 However, new paradigms are needed to interpret toxicogenomic and nanotoxicological data in order to predict drug toxicities and gain a more indepth understanding of the mechanisms of toxicity, so that more specific therapeutic targets which are essentially devoid of side effects could be selected.23,24
Post to:
Cannotea
Citeulike
Del.icio.us
Facebook
LinkedIn
?
Other articles by Dr Farooq A. Shiekh
Readers of this article also read:
jadeveon clowney orange bowl Rose Parade 2013 rex ryan PNC Bank Louisville football Fidelity
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন